Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal)

Technology appraisal
Reference number: TA240
Published: 14 December 2011
Last updated: 29 March 2017

Update information

March 2017: The population covered by the marketing authorisation for panitumumab changed from 'patients with wild-type KRAS metastatic colorectal cancer' to 'patients with wild-type RAS metastatic colorectal cancer'.

ISBN: 978-1-4731-2442-4